The expression of co-suppressor molecules in TME is the underlying mechanism of tumor immune escape, and targeting the PD-1/PD-L1 co-inhibitory axis demonstrates that blocking co-inhibitory signaling can reactivate T cells to mediate tumor elimination or control. Here, PDCD1 is linked to neoplasm.